Bracke S - Search Results

1

An elastic liposomal formulation for RNAi-based topical treatment of skin disorders: Proof-of-concept in the treatment of psoriasis.

Desmet E, Bracke S, Forier K, Taevernier L, Stuart MC, De Spiegeleer B, Raemdonck K, Van Gele M, Lambert J. Desmet E, et al. Among authors: bracke s. Int J Pharm. 2016 Mar 16;500(1-2):268-74. doi: 10.1016/j.ijpharm.2016.01.042. Epub 2016 Jan 19. Int J Pharm. 2016. PMID: 26806466

2

Identifying targets for topical RNAi therapeutics in psoriasis: assessment of a new in vitro psoriasis model.

Bracke S, Desmet E, Guerrero-Aspizua S, Tjabringa SG, Schalkwijk J, Van Gele M, Carretero M, Lambert J. Bracke S, et al. Arch Dermatol Res. 2013 Aug;305(6):501-12. doi: 10.1007/s00403-013-1379-9. Epub 2013 Jun 18. Arch Dermatol Res. 2013. PMID: 23775225

3

Lipid-mediated gene delivery to the skin.

Geusens B, Strobbe T, Bracke S, Dynoodt P, Sanders N, Van Gele M, Lambert J. Geusens B, et al. Among authors: bracke s. Eur J Pharm Sci. 2011 Jul 17;43(4):199-211. doi: 10.1016/j.ejps.2011.04.003. Epub 2011 Apr 16. Eur J Pharm Sci. 2011. PMID: 21515366 Review.

4

Viewpoint on handling anti-TNF failure in psoriasis.

Bracke S, Lambert J. Bracke S, et al. Arch Dermatol Res. 2013 Dec;305(10):945-50. doi: 10.1007/s00403-013-1418-6. Epub 2013 Oct 6. Arch Dermatol Res. 2013. PMID: 24096701

5

Targeted silencing of DEFB4 in a bioengineered skin-humanized mouse model for psoriasis: development of siRNA SECosome-based novel therapies.

Bracke S, Carretero M, Guerrero-Aspizua S, Desmet E, Illera N, Navarro M, Lambert J, Del Rio M. Bracke S, et al. Exp Dermatol. 2014 Mar;23(3):199-201. doi: 10.1111/exd.12321. Exp Dermatol. 2014. PMID: 24428418

6

Characterization data on the topical carrier DDC642.

Desmet E, Bracke S, Forier K, Taevernier L, Stuart MC, De Spiegeleer B, Raemdonck K, Van Gele M, Lambert J. Desmet E, et al. Among authors: bracke s. Data Brief. 2016 Apr 1;7:1204-10. doi: 10.1016/j.dib.2016.03.091. eCollection 2016 Jun. Data Brief. 2016. PMID: 27408923 Free PMC article.

7

Exploring the feasibility of whole blood to identify systemic miRNA biomarkers for patients with moderate to severe psoriasis.

Van Gele M, Bracke S, Alves de Medeiros AK, Lambert J. Van Gele M, et al. Among authors: bracke s. Eur J Dermatol. 2016 Apr 1;26(2):195-8. doi: 10.1684/ejd.2015.2710. Eur J Dermatol. 2016. PMID: 27098680 No abstract available.

8

An educational programme for patients with psoriasis and atopic dermatitis: a prospective randomized controlled trial.

Bostoen J, Bracke S, De Keyser S, Lambert J. Bostoen J, et al. Among authors: bracke s. Br J Dermatol. 2012 Nov;167(5):1025-31. doi: 10.1111/j.1365-2133.2012.11113.x. Epub 2012 Sep 7. Br J Dermatol. 2012. PMID: 22709422 Clinical Trial.

9

Evaluation of commercially available ELISA assays as a tool for monitoring and managing pemphigus patients: a prospective study.

Bracke S, Speeckaert R, Van Geel N, De Bacquer D, Lambert J. Bracke S, et al. Eur J Dermatol. 2013 Jan-Feb;23(1):33-9. doi: 10.1684/ejd.2012.1901. Eur J Dermatol. 2013. PMID: 23302186

10

Serum plakophilin-3 autoreactivity in paraneoplastic pemphigus.

Lambert J, Bracke S, van Roy F, Pas HH, Bonné S, De Schepper S. Lambert J, et al. Among authors: bracke s. Br J Dermatol. 2010 Sep;163(3):630-2. doi: 10.1111/j.1365-2133.2010.09845.x. Br J Dermatol. 2010. PMID: 20456348

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

43 results

Search Page